Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Svizzera | Salute | Prodotti farmaceutici | 630,86 Mrd CHF | 85,7x | 1,27 | 660 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Roche Holding | Svizzera | Salute | Prodotti farmaceutici | 205,21 Mrd CHF | 19,1x | -5,94 | 270,80 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,6% Rialzo | Fai l’upgrade a Pro+ | |
Roche Holding Participation | Svizzera | Salute | Prodotti farmaceutici | 205,21 Mrd CHF | 20,3x | -5,94 | 255,50 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,9% Rialzo | Fai l’upgrade a Pro+ | |
Novartis | Svizzera | Salute | Prodotti farmaceutici | 186,47 Mrd CHF | 12,2x | 0,14 | 93,27 CHF | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,8% Rialzo | Fai l’upgrade a Pro+ | |
Novartis | Svizzera | Salute | Prodotti farmaceutici | 186,47 Mrd CHF | 12,2x | 0,14 | 92,92 CHF | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Abbott Laboratories | Svizzera | Salute | Attrezzature e forniture medicali | 181,47 Mrd CHF | 36,1x | 2,98 | 93,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Alcon | Svizzera | Salute | Attrezzature e forniture medicali | 38,77 Mrd CHF | 37,9x | 0,24 | 78,38 CHF | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,4% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,02 Mrd CHF | 58x | -1,38 | 526,40 CHF | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,7% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 38,02 Mrd CHF | 58x | -1,38 | 526,40 CHF | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,7% Rialzo | Fai l’upgrade a Pro+ | |
Zimmer Biomet Holdings Inc | Svizzera | Salute | Attrezzature e forniture medicali | 19,66 Mrd CHF | 21,2x | 0,16 | 109 CHF | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Straumann Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 18,28 Mrd CHF | 66,8x | -2,27 | 114,65 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,4% Rialzo | Fai l’upgrade a Pro+ | |
Sonova Holding | Svizzera | Salute | Attrezzature e forniture medicali | 17,93 Mrd CHF | -5,39 | 228,60 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Sonova H Ag | Svizzera | Salute | Attrezzature e forniture medicali | 17,93 Mrd CHF | 31,7x | -5,39 | 300,80 CHF | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -2,8% Ribasso | Fai l’upgrade a Pro+ | |
Sandoz | Svizzera | Salute | Prodotti farmaceutici | 17,61 Mrd CHF | -2.379,2x | 24,68 | 40,14 CHF | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,5% Rialzo | Fai l’upgrade a Pro+ | |
BACHEM HOLDING AG | Svizzera | Salute | Ricerca medica e biotecnologica | 5,11 Mrd CHF | 44,5x | 3,05 | 68,10 CHF | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,9% Rialzo | Fai l’upgrade a Pro+ | |
Ypsomed Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 4,89 Mrd CHF | 65,1x | 25,09 | 358 CHF | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 25,7% Rialzo | Fai l’upgrade a Pro+ | |
Siegfried Holding Ltd | Svizzera | Salute | Prodotti farmaceutici | 4,78 Mrd CHF | 36,7x | -2,55 | 1.114 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,9% Rialzo | Fai l’upgrade a Pro+ | |
Galenica Sante | Svizzera | Salute | Prodotti farmaceutici | 3,82 Mrd CHF | 21,5x | -0,66 | 76,65 CHF | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,1% Rialzo | Fai l’upgrade a Pro+ | |
Dottikon Es Holding AG | Svizzera | Salute | Prodotti farmaceutici | 3,22 Mrd CHF | 42,6x | 233 CHF | -2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Lepu Medical Tech Beijing DRC | Svizzera | Salute | Attrezzature e forniture medicali | 2,69 Mrd CHF | 34,2x | -0,53 | 15,85 CHF | 12,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Joincare Pharmaceutical DRC | Svizzera | Salute | Prodotti farmaceutici | 2,62 Mrd CHF | 14,9x | 4,92 | 7,04 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medacta | Svizzera | Salute | Attrezzature e forniture medicali | 2,20 Mrd CHF | 46,2x | 3,28 | 110,40 CHF | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,4% Rialzo | Fai l’upgrade a Pro+ | |
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 2,05 Mrd CHF | 16,2x | 0,12 | 37,35 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 49,5% Rialzo | Fai l’upgrade a Pro+ | |
SKAN | Svizzera | Salute | Attrezzature e forniture medicali | 1,67 Mrd CHF | 55,9x | 2,89 | 74,30 CHF | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 21,1% Rialzo | Fai l’upgrade a Pro+ | |
Aevis Victoria | Svizzera | Salute | Fornitori e servizi sanitari | 1,18 Mrd CHF | -40,1x | 0,02 | 14 CHF | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
COSMO Pharma | Svizzera | Salute | Prodotti farmaceutici | 1,01 Mrd CHF | 15,6x | 0,03 | 63,20 CHF | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,9% Rialzo | Fai l’upgrade a Pro+ | |
PolyPeptide Group AG | Svizzera | Salute | Prodotti farmaceutici | 954,88 Mln CHF | -35x | -1,65 | 28,95 CHF | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,9% Rialzo | Fai l’upgrade a Pro+ | |
Kuros Biosciences | Svizzera | Salute | Ricerca medica e biotecnologica | 834,12 Mln CHF | -72,1x | -2,99 | 22,20 CHF | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medartis | Svizzera | Salute | Attrezzature e forniture medicali | 761,35 Mln CHF | 176,9x | 1,2 | 56 CHF | -2,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Basilea Pharmaceutica AG | Svizzera | Salute | Ricerca medica e biotecnologica | 505,45 Mln CHF | -767,6x | 7,66 | 41,70 CHF | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |